4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-16-000174
CIK 0001000229operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:05 PM ET
Size
10.1 KB
Accession
0001000229-16-000174
Insider Transaction Report
Form 4
Dunlap Charles L
Director
Transactions
- Tax Payment
Common Shares
2016-03-31$112.41/sh−6$674→ 1,882 total - Exercise/Conversion
Restricted Shares
2016-03-31−1,088→ 0 totalExercise: $0.00→ Common Shares (1,088 underlying) - Exercise/Conversion
Common Shares
2016-03-31+1,088→ 1,888 total - Award
Restricted Shares
2016-04-01+1,335→ 1,335 totalExercise: $0.00→ Common Shares (1,335 underlying)
Footnotes (2)
- [F1]The Restricted Shares vested at the end of a three-year vesting period ending March 31, 2016.
- [F2]The Restricted Shares will vest, without performance criteria, at the end of a three-year vesting period ending April 1, 2019, subject to the terms of issuance.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:05 PM ET
- Size
- 10.1 KB